Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kishida Y et al. – Chemotherapy–induced neutropenia is a predictor of better survival for patients with advanced NSCLC. Prospective randomised trials of early–dose increases guided by chemotherapy–induced toxicities are warranted.

Today in Chemotherapy/Oncology...keeping you current

Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice & Research: Clinical Haematology , 12/08/09

New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address